---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-029700"
form_type: "8-K"
ticker: "ELTP"
cik: "0001053369"
company_name: "ELITE PHARMACEUTICALS INC /NV/"
filed_at: "2026-06-23T11:02:37+00:00"
generated_at: "2026-06-23T11:05:12.804002+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Elite Pharmaceuticals to release FY2026 results on June 29, host call on June 30

## Summary
- FY2026 (ended March 31, 2026) financial results to be released Monday, June 29, 2026.
- Conference call Tuesday, June 30, 2026 at 11:30 AM EDT; dial-in 1-800-346-7359, conference code 98840.
- General questions due by 5:00 PM EDT on June 26; financial questions by 7:00 PM EDT on June 29.
- Management will provide a corporate update and discuss results during the call.

## SEC filing metadata
- accession: 0001493152-26-029700
- form_type: 8-K
- ticker: ELTP
- cik: 0001053369
- company_name: ELITE PHARMACEUTICALS INC /NV/
- filed_at: 2026-06-23T11:02:37+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 7.01, 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1053369/000149315226029700/0001493152-26-029700-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1053369/000149315226029700/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-029700
- JSON: https://secwatch.observer/filing/0001493152-26-029700.json
- Plain text: https://secwatch.observer/filing/0001493152-26-029700.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.